Edwards Lifesciences Corp (EW)

Return on equity (ROE)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	4,174,600	1,402,400	1,521,900	1,503,100	823,400
Total stockholders’ equity	US$ in thousands	9,998,400	6,650,000	5,806,700	5,835,900	4,574,300
ROE		41.75%	21.09%	26.21%	25.76%	18.00%

December 31, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $4,174,600K ÷ $9,998,400K
= 41.75%

Edwards Lifesciences Corp has shown a positive trend in its return on equity (ROE) over the past five years. The ROE has increased from 18.00% as of December 31, 2020, to 41.75% as of December 31, 2024. This indicates that the company has been effectively utilizing its equity to generate profits for its shareholders. The significant improvement in ROE reflects the company's ability to efficiently allocate resources and generate higher returns on equity investments. Overall, the increasing ROE demonstrates Edwards Lifesciences Corp's strong financial performance and efficient management of shareholder equity.